Other Rules - Emergency Rulemaking Archives

*free viewer or to request a hard copy

Emergency Other Rules

Department of Health and Human Services-General; Chapter 275-Reporting and Fee Requirements for Pharmaceutical Manufacturers and Labelers - Joint Rule with Dept. of Atty. General (Ch 111) WORD  PDF   
Concise Summary: This emergency rule repeals Office of the Attorney General Chapter 111, Reporting Requirements for Pharmaceutical Manufacturers and Labelers, and Department of Health and Human Services Chapter 275, Section 1-Prescription Drug Clinical Trial Reporting, Section 2-Reporting of Prescription Drug Marketing Costs and Section 3-Fee Provision to implement Prescription Privacy Laws. The 125th Maine Legislature enacted PL 2007 on June 29, 2011, which repealed the statutory provisions that authorized the Department to require marketing and clinical drug trial reporting and supported the Attorney General’s position in adopting clinical drug trial reporting requirements as a trade practice. In addition, the federal District Court rendered a decision that the Maine prescription drug privacy statutory provision is unconstitutional, following a recent Supreme Court decision.
Effective Date: November 8, 2011
 
Department of Health & Human Services, Chapter 107, Medical Eye Care Program WORD  PDF   
Concise Summary: The emergency adopted rule repeals 10-144, Chapter 107, Medical Eye Care Program, as it is a state funded DHHS benefit that has not had funding since the previous fiscal year. No additional funds are available for this program in the upcoming state fiscal years.
Effective Date: November 8, 2011